Cognios Beta Neutral Large Cap Fund, LP Abb Vie Inc. Transaction History
Cognios Beta Neutral Large Cap Fund, LP
- $74.5 Million
- Q1 2024
A detailed history of Cognios Beta Neutral Large Cap Fund, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Cognios Beta Neutral Large Cap Fund, LP holds 3,011 shares of ABBV stock, worth $532,796. This represents 0.74% of its overall portfolio holdings.
Number of Shares
3,011
Previous 3,742
19.54%
Holding current value
$532,796
Previous $579,000
5.35%
% of portfolio
0.74%
Previous 0.78%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,848Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.4 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.22 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.85 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $313B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...